High CXC Chemokine Receptor 1 Level Represents an Independent Negative Prognosticator in Non-Metastatic Clear-Cell Renal Cell Carcinoma Patients

OncoImmunology - United States
doi 10.1080/2162402x.2017.1359450
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Potential Roles for PD‐1 and Cabozantinib in Patients With Metastatic Non‐Clear Cell Renal Cell Carcinoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Prognostic Value of Granulocyte Colony-Stimulating Factor in Patients With Non-Metastatic Clear Cell Renal Cell Carcinoma

Oncotarget
Oncology
2017English

Clinical Impact of Targeted Therapies in Patients With Metastatic Clear-Cell Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2014English

Beta-1,4-Galactosyltransferase II Predicts Poor Prognosis of Patients With Non-Metastatic Clear-Cell Renal Cell Carcinoma

Tumor Biology
MedicineCancer Research
2017English

Systemic Therapy for Metastatic Non–Clear-Cell Renal Cell Carcinoma: Recent Progress and Future Directions

Hematology/Oncology Clinics of North America
OncologyHematology
2011English

Low Level of Isocitrate Dehydrogenase 1 Predicts Unfavorable Postoperative Outcomes in Patients With Clear Cell Renal Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Clear Cell Papillary Renal Cell Carcinoma

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2019English

Subtotal Distal Pancreatectomy for Metachronous Metastatic Renal Clear Cell Carcinoma

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2012English

High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy